3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
18
Prostatic Neoplasms
14
Lung Neoplasms
13
Colorectal Neoplasms
13
Lymphoma
5
Hematologic Neoplasms
5
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Hematopoietic and Lymphatic System Neoplasm
4
Anatomic Stage I Breast Cancer AJCC v8
4
Triple Negative Breast Neoplasms
3
Papillomavirus Infections
3
Pancreatic Neoplasms
3
Obesity-Related Malignant Neoplasm
3
Melanoma
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Skin Carcinoma
2
Neoplasms
2
Multiple Myeloma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphoid System Neoplasm
2
Healthy Subject
2
Genital Neoplasms, Female
2
Endometrial Neoplasms
2
Breast Carcinoma In Situ
2
Advanced Malignant Solid Neoplasm
2
Vulvar Neoplasms
1
Interventions
Temozolomide
15
Radiotherapy
10
Radiation
8
Magnetic Resonance Spectroscopy
7
pembrolizumab
5
Specimen Handling
5
Ipilimumab
3
atezolizumab
2
Photons
2
Nivolumab
2
Biopsy
2
veliparib
1
selinexor
1
sargramostim
1
plerixafor
1
peposertib
1
pazopanib
1
navtemadlin; 2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid
1
montanide ISA 51
1
liposomal doxorubicin
1
gosha-jinki-gan
1
fluorodopa F 18
1
ferric pyrophosphate
1
efineptakin alfa
1
cemiplimab
1
cabozantinib
1
balstilimab
1
abexinostat
1
X-Rays
1
Vorinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gliosarcoma
×
Early Intervention, Educational
×
1 year
×
Clear all
No trials found.